Research & Development

Can Engineered Bacteria Lead the Future of Cancer Treatment?
Research & Development Can Engineered Bacteria Lead the Future of Cancer Treatment?

The relentless pursuit of highly effective oncological interventions has historically been hampered by the inability of traditional pharmaceutical agents to distinguish accurately between malignant cells and healthy physiological structures. While chemotherapy and systemic radiation have saved

How Does Ezrin’s Dual Role Drive Bone Cancer Spread?
Research & Development How Does Ezrin’s Dual Role Drive Bone Cancer Spread?

The silent progression of osteosarcoma remains one of the most daunting challenges in modern pediatric oncology, often remaining undetected until the malignancy has already begun its journey to distant organs. While medical science has mastered the art of treating localized bone tumors through a

Is TBC1D9B the Master Switch for Cellular Metabolism?
Research & Development Is TBC1D9B the Master Switch for Cellular Metabolism?

The human cell operates as a high-speed logistics hub where the physical location of cargo determines the fate of the entire biological operation. For decades, biology textbooks have described lysosomes as simple waste disposal units—tiny acidic balloons drifting through the cytoplasm to dissolve

How Does Biological Sex Affect Cancer Treatment Outcomes?
Research & Development How Does Biological Sex Affect Cancer Treatment Outcomes?

Groundbreaking research involving more than twenty thousand oncology patients has finally pulled back the curtain on a quiet crisis where medical treatments are inadvertently failing to account for the fundamental biological differences between men and women. For decades, the medical community

Mirum Completes Enrollment for Phase 3 Maralixibat Trial
Research & Development Mirum Completes Enrollment for Phase 3 Maralixibat Trial

The relentless physical and psychological burden of chronic cholestatic pruritus often defines the daily existence of patients long before a clinical diagnosis is even finalized. For those living with rare liver diseases, the sensation of an internal, unreachable itch is not merely a symptom but a

Scientists Map the Origins of Rare Pediatric Liver Cancer
Research & Development Scientists Map the Origins of Rare Pediatric Liver Cancer

Pediatric liver cancer research has entered a transformative era with the identification of Hepatoblastoma with carcinoma features (HBC), a complex third category that bridges the gap between traditional hepatoblastoma and hepatocellular carcinoma. Ivan Kairatov, a biopharma expert with extensive

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later